James REBBEOR,Charles MILLER,Anthony KLOS,Eric ALLGAIER,Thomas P ZIMMERMAN,Kevin WEE,Michelle StPETER,Kelly GLANCY
申请号：
CL2019002131
公开号：
CL2019002131A1
申请日:
2019.07.30
申请国别(地区):
CL
年份:
2020
代理人:
摘要：
Compositions include highly-concentrated Alpha-1 Proteinase Inhibitor (A1PI) in a concentration greater than or equal to 100 mg/ml. Pharmaceutical compositions can be prepared from these compositions. The pharmaceutical compositions can be suitable for subcutaneous administration. The highly-concentrated A1PI solutions can be obtained by single-pass tangential flow filtration (SPTFF).COMPOSICIÓN QUE COMPRENDE INHIBIDOR DE LA ALFA-1 PROTEINASA ALTAMENTE CONCENTRADO Y PROCEDIMIENTO PARA LA OBTENCIÓN DE LA MISMA
